Pierre Sayad - Nov 13, 2024 Form 4 Insider Report for FENNEC PHARMACEUTICALS INC. (FENC)

Role
Chief Medical Officer
Signature
/s/ Pierre Sayad
Stock symbol
FENC
Transactions as of
Nov 13, 2024
Transactions value $
$634,500
Form type
4
Date filed
11/13/2024, 05:13 PM
Previous filing
Nov 4, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FENC Stock Options Award $635K +150K $4.23 150K Nov 13, 2024 Common Shares 150K $4.23 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On November 13, 2024, Pierre Sayad was granted incentive stock options to purchase 150,000 shares of the issuers common shares pursuant to the Issuer's 2020 Equity Incentive Plan.
F2 One-third of the shares subject to this option may be exercised as of November 13, 2025 ("Vesting Commencement Date"). One twenty-fourth of the shares subject to this option shall vest and may be exercised as of the last day of each month following the Vesting Commencement Date until all shares have vested.